Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reserpine in Refractory Hypertension
NCT03223272Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reserpine in hypertension (HTN), sponsored by University of Alabama at Birmingham. Started Jul 2015; status: completed.
02
Drugs
reserpine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03223272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223272.